Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Brenckman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA|June 26, 1981
Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancerW D Brenckman, L B Lastinger, F Sedor
American Journal of Clinical Pathology|May 1, 1986
Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulinsW L Gluck, S H Bigner, M J Borowitz, et al.
Thrombosis Research|February 15, 1987
Evidence for the involvement of platelet glycoproteins other than GP Ib in heparin-associated thrombocytopenia and thrombosisR G Makhoul, D V Devine, W D Brenckman, et al.
British Journal of Haematology|October 1, 1976
Fragmentation haemolysis in patients with severe diabetic angiopathyR D Brunning, H S Jacob, W D Brenckman, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Initial clinical studies of piritreximJ Laszlo, W D Brenckman, E Morgan, et al.
Annals of Internal Medicine|July 15, 1988
Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphomaC C Chua, M L Greenberg, A T Viau, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and manJ C Cavallito, C A Nichol, W D Brenckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Clinical experience with CF-FUraL R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer|March 15, 1989
Clinical experience with leucovorin and 5-fluorouracilL R Laufman, W D Brenckman, K A Stydnicki, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA|June 26, 1981
Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancerW D Brenckman, L B Lastinger, F Sedor
American Journal of Clinical Pathology|May 1, 1986
Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulinsW L Gluck, S H Bigner, M J Borowitz, et al.
Thrombosis Research|February 15, 1987
Evidence for the involvement of platelet glycoproteins other than GP Ib in heparin-associated thrombocytopenia and thrombosisR G Makhoul, D V Devine, W D Brenckman, et al.
British Journal of Haematology|October 1, 1976
Fragmentation haemolysis in patients with severe diabetic angiopathyR D Brunning, H S Jacob, W D Brenckman, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Initial clinical studies of piritreximJ Laszlo, W D Brenckman, E Morgan, et al.
Annals of Internal Medicine|July 15, 1988
Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphomaC C Chua, M L Greenberg, A T Viau, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and manJ C Cavallito, C A Nichol, W D Brenckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Clinical experience with CF-FUraL R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer|March 15, 1989
Clinical experience with leucovorin and 5-fluorouracilL R Laufman, W D Brenckman, K A Stydnicki, et al.
Pageof 2